文献
J-GLOBAL ID:201802281180801474
整理番号:18A0555011
改良されたクロラムブシル乳癌治療のためのキノンメチド仲介GSH枯渇による活性酸素種応答ナノプロドラッグ
Reactive oxygen species-responsive nanoprodrug with quinone methides-mediated GSH depletion for improved chlorambucil breast cancers therapy
著者 (21件):
Luo Cheng-Qiong
(State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China)
,
Luo Cheng-Qiong
(Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, China Pharmaceutical University, Nanjing 210009, China)
,
Luo Cheng-Qiong
(Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, China)
,
Luo Cheng-Qiong
(Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, China)
,
Zhou Yu-Xin
(State Key Laboratory of Natural Medicines, College of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China)
,
Zhou Tian-Jiao
(State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China)
,
Xing Lei
(State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China)
,
Xing Lei
(Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, China Pharmaceutical University, Nanjing 210009, China)
,
Xing Lei
(Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, China)
,
Xing Lei
(Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, China)
,
Cui Peng-Fei
(State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China)
,
Sun Minjie
(State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China)
,
Jin Liang
(State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China)
,
Jin Liang
(Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, China Pharmaceutical University, Nanjing 210009, China)
,
Jin Liang
(Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, China)
,
Jin Liang
(School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China)
,
Lu Na
(State Key Laboratory of Natural Medicines, College of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China)
,
Jiang Hu-Lin
(State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China)
,
Jiang Hu-Lin
(Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, China Pharmaceutical University, Nanjing 210009, China)
,
Jiang Hu-Lin
(Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, China)
,
Jiang Hu-Lin
(Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, China)
資料名:
Journal of Controlled Release
(Journal of Controlled Release)
巻:
274
ページ:
56-68
発行年:
2018年03月28日
JST資料番号:
C0308D
ISSN:
0168-3659
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)